We studied the immune responses to heat shock protein (Hsp)-27 and pro-oxidant–antioxidant balance (PAB) values in patients with valvular heart disease, but free of angiographically evident coronary artery disease (CAD). Patients who were candidates for valvuloplasty surgery and 30 healthy matched controls were recruited. The anti-Hsp-27 antibody titers were 0.35 ± 0.04 absorbency units (AU) in the valvuloplasty group, being significantly higher than for the controls (0.11 ± 0.02 AU; P < .05). The PAB values were significantly higher in cases (134.67 ± 13.69 Hamidi-Koliakos(HK) unit) when compared with controls (49.78 ± 6.75 HK unit; P < .05). In cases, the ejection fraction was inversely correlated with anti-Hsp-27 antibody (P < .05) but was not significantly related to PAB values (P > .05). Based on the echocardiographic findings, the patients had no evident heart failure, but the high levels of anti-Hsp-27 and PAB values in patients with valvular heart disease may indicate that these variables can be used as markers of heart failure. However, a longitudinal study is required to confirm this hypothesis.
O'BrienKD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol. 2006;26(8):1721–1728.
DavutogluVCelikAAksoyM. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis. 2005;14(2):251–256.
4.
LinSLLiuCPChenCY. The relation between thickened aortic valve and coronary artery disease. Zhonghua Yi Xue Za Zhi (Taipei). 1997;60(2):92–97.
5.
FilipDANistorABullaA. Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia. Atherosclerosis. 1987;67(2-3):199–214.
6.
AronowWSSchwartzKSKoenigsbergM. Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility. Am J Cardiol. 1987;59(12):381–382.
7.
OlssonMThybergJNilssonJ. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol. 1999;19(5):1218–1222.
8.
WalterMFJacobRFJeffersB. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J Am Coll Cardiol. 2004;44(10):1996–2002.
9.
Kotur-StevuljevicJMemonLStefanovicA. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem. 2007;40(3-4):181–187.
10.
BetteridgeDJ. What is oxidative stress?Metabolism. 2000;49(2 suppl 1):3–8.
WitztumJL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344(8925):793–795.
13.
AlamdariDHPaletasKPegiouT. A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem. 2007;40(3-4):248–254.
14.
AlamdariDHGhayour-MobarhanMTavallaieS. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem. 2008;41(6):375–380.
15.
Ghayour-MobarhanMRahseparAATavallaieS. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Adv Clin Chem. 2009;48:27–72.
16.
VeresASzamosiTAblonczyM. Complement activating antibodies against the human 60 kDa heat shock protein as a new independent family risk factor of coronary heart disease. Eur J Clin Invest. 2002;32(6):405–410.
17.
Ghayour-MobarhanMSahebkarAParizadehSM. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. Int J Exp Pathol. 2008;89(3):209–215.
18.
XuQWilleitJMarosiM. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993;341(8840):255–259.
19.
GreenlandPSmithSCJrGrundySM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104(15):1863–1867.
20.
TavallaieSRahseparAAAbdiH. Association between indices of body mass and antibody titers to heat-shock protein- 27 in healthy subjects. Clin Biochem. 2011;45:144–147.
21.
Ghayour-MobarhanMAlamdariDHMoohebatiM. Determination of prooxidant–antioxidant balance after acute coronary syndrome using a rapid assay: a pilot study. Angiology. 2009;60(6):657–662.
22.
FalsoleimanHDehghaniMMoohebatiM. Changes in pro-oxidant-antioxidant balance after bare metal and drug eluting stent implantation in patients with stable coronary disease. Clin Biochem. 2011;44(2-3):160–164.
23.
MartinJLMestrilRHilal-DandanR. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation. 1997;96(12):4343–4348.
24.
BeattyWLMorrisonRPByrneGI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 1994;58(4):686–699.
25.
BoulangerCMScoazecAEbrahimianT. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001;104(22):2649–2652.
HoppichlerFLechleitnerMTrawegerC. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis. 1996;126(2):333–338.
28.
XuQWilleitJMarosiM. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993;341(8840):255–259.
29.
MillerJDWeissRMSerranoKM. Lowering plasma cholesterol levels halts progression of aortic valve disease in mice. Circulation. 2009;119(20):2693–2701.
30.
MazzoneAEpistolatoMCDeCR. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol. 43(9):1670-1676
31.
TsutsuiHIdeTHayashidaniS. Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. Cardiovasc Res. 2001;49(1):103–109.
32.
WhiteMDucharmeAIbrahimR. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. Clin Sci (Lond). 2006;110(4):483–489.
33.
SivasubramanianNCokerMLKurrelmeyerKM. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 2001;104(7):826–831.
34.
ChengWKajsturaJNitaharaJA. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 1996;226(2):316–327.
35.
BrarBKStephanouAWagstaffMJ. Heat shock proteins delivered with a virus vector can protect cardiac cells against apoptosis as well as against thermal or hypoxic stress. J Mol Cell Cardiol. 1999;31(1):135–146.
36.
GarridoCBrueyJMFromentinA. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 13(14):2061-2070
37.
LiuLZhangXQianB. Over-expression of heat shock protein 27 attenuates doxorubicin-induced cardiac dysfunction in mice. Eur J Heart Fail. 2007;9(8):762–769.
38.
DohkeTWadaAIsonoT. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Card Fail. 2006;12(1):77–84.
39.
GusevNBBogatchevaNVMarstonSB. Structure and properties of small heat shock proteins (sHsp) and their interaction with cytoskeleton proteins. Biochemistry (Mosc). 2002;67(5):511–519.
40.
LibermanMBassiEMartinattiMK. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28(3):463–470.
41.
MillerJDChuYBrooksRM. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. 2008;52(10):843–850.
42.
WeissRMOhashiMMillerJD. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006;114(19):2065–2069.
43.
KangPMHaunstetterAAokiH. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res. 2000;87(2):118–125.
44.
EllisGRAndersonRALangD. Neutrophil superoxide anion–generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. J Am Coll Cardiol. 2000;36(5):1474–1482.
45.
YucelDAydogduSSenesM. Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy. Scand J Clin Lab Invest. 2002;62(6):463–468.
46.
KorantzopoulosPGalarisDPapaioannidesDSiogasK. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med Sci Monit. 2003;9(6):RA120–RA125.
47.
BelchJJBridgesABScottNChopraM. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65(5):245–248.
48.
MallatZPhilipILebretM. Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation. 1998;97(16):1536–1539.
49.
ToliKParaskevasKIPoulakouMV. Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment?Expert Opin Ther Targets. 2008;12(10):1209–1215.
50.
GombosTForheczZPozsonyiZ. Interaction of serum 70-kDa heat shock protein levels and HspA1B (+1267) gene polymorphism with disease severity in patients with chronic heart failure. Cell Stress Chaperones. 2008;13(2):199–206.
51.
BurutDFKarimYFernsGA. The role of immune complexes in atherogenesis. Angiology. 2010;61(7):679–689.
